Search

everythinglearnresearchcommunity

for

Search:↓

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

SIG-1451 could be a promising new treatment for atopic dermatitis.

New treatments for relapsing multiple sclerosis are more effective and convenient but have higher risks of serious side effects.

Vaccines and targeting TrxR variants can help prevent cancer and reduce metastasis.

Rituximab leads to longer remission and fewer side effects than cyclophosphamide.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

A woman with advanced eye cancer went into complete remission using a combination of immunotherapy and topical treatments.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

XEDAR triggers a specific signaling pathway in cells.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Betulinic acid can help treat hepatitis C by stopping virus replication.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

DNCB is highly effective for treating alopecia areata with minimal long-term side effects.

High CCL11 levels may indicate poor response to baricitinib in severe alopecia areata.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

Combining specific nanoparticles with immune therapy significantly improves cancer treatment.

Oral feline interferon-omega improved symptoms in diabetic cats with gingivostomatitis.

Tofacitinib is a promising treatment for children with rheumatic diseases.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

Activating cannabinoid receptor 1 reduces certain keratin levels, potentially aiding psoriasis treatment.

Blocking the protein CXCL12 with a specific antibody can increase hair growth in common hair loss conditions.

Blocking IL-8 can reduce skin rashes from cancer treatment.

DHA-NLC may improve drug delivery and reduce side effects for cancer treatment.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.